Form 8-K Summary
Registrant: Venus Acquisition Corporation, a Cayman Islands exempt company and special purpose acquisition company. The provided metadata identifies Microalgo Inc., but the filing itself names Venus Acquisition Corporation as the registrant.
Reporting date: February 11, 2021, covering the effectiveness of the IPO registration statement, IPO closing, and related private placement.
Business Context and Transaction
- The SEC declared the company’s IPO registration statement effective on February 8, 2021.
- On February 11, 2021, the company completed its IPO of 4,600,000 units, including the underwriters’ full exercise of the 600,000-unit over-allotment option.
- Each public unit included one ordinary share, one warrant exercisable for one-half of an ordinary share at $11.50 per whole share, and one right to receive one-tenth of an ordinary share upon completion of an initial business combination.
- The company also sold 225,000 private units to its sponsor, Yolanda Management Corporation.
Financial Metrics, Capitalization, and Liquidity
| Item | Amount or Terms |
|---|---|
| Public units issued | 4,600,000 |
| Public offering price | $10.00 per unit |
| Gross IPO proceeds | $46.6 million |
| Private placement proceeds | $2.25 million |
| Net proceeds deposited in trust | $46.46 million as of February 11, 2021 |
| Public warrant exercise price | $11.50 per whole share |
| Sponsor note offset against private placement subscription | $289,000 |
| Additional shares sold to underwriters | 75,000 shares for $75 |
The filing does not provide operating revenue, profit, cash flow, margins, or debt metrics for a comparable period. An audited balance sheet as of February 11, 2021 was expected to be filed separately within four business days.
Material Changes and Unusual Items
- The company transitioned from pre-IPO formation to a publicly traded SPAC following completion of the IPO.
- The sponsor’s $289,000 outstanding loan was offset against the sponsor’s private-unit purchase price rather than repaid in cash.
- The sponsor holds registration rights covering its ordinary shares, private units, and certain securities issuable from future working-capital loans.
- The company entered into underwriting, warrant, rights, insider, trust, and registration rights agreements. Their detailed terms are incorporated by reference to the IPO registration statement.
Outlook, Risks, and Contingencies
- The filing is transaction-focused and does not identify a target business, provide earnings guidance, or state a projected business-combination timetable.
- Trust-account funds are intended for the benefit of public shareholders and are subject to the company’s business-combination structure and related redemption provisions, as described in the registration statement.
- Investors should review the registration statement for sponsor incentives, dilution from warrants and rights, redemption mechanics, permitted working-capital financing, and the conditions governing any future business combination.
Key Facts to Verify
- Confirm the registrant identity: the filing names Venus Acquisition Corporation, not Microalgo Inc.
- Verify the subsequently filed audited balance sheet and the final allocation of IPO proceeds, offering expenses, and trust-account funds.
- Review the IPO registration statement and underwriting agreement for complete economic terms and redemption rights.
- Assess dilution from 4,600,000 public warrants, 4,600,000 public rights, 225,000 private units, sponsor shares, and any future working-capital securities.
- Confirm the terms and status of the sponsor’s $289,000 loan offset and the sponsor’s registration rights.